Global At-home Saliva Testing Kit Market

At-home Saliva Testing Kit Comprehensive Study by Type (Test Strip, Cassette), Indication (Malaria, Ovulation, HIV, COVID, Others), Distribution Channel (Drugstores, Retail Pharmacies, Hospital Chain Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2026

At-home Saliva Testing Kit Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global At-home Saliva Testing Kit Market Overview:
The demand for saliva-based home test kits is likely to expand at a healthy rate. With the rising number of infection cases, demand for these saliva-based home test kits has increased, with the goal of reducing the time it takes to detect infected people. These test kits differ from home-collection test kits, in which a sample is collected at home and delivered to a laboratory for a week's worth of results. The main advantages of using a saliva sample over a blood sample are its ease of collection, cost-effectiveness, safety, non-invasiveness, and user-friendliness, as well as the number of biomarkers such as genetic material and proteins contained in saliva.

Growth Drivers
  • Rising adoption of self-help and do-it-yourself (DIY) test kits due to convenience and rapid results
  • Increasing incidence of diseases such as HIV

Roadblocks
  • High cost of the kit

Opportunities
  • Increasing awareness amongst the population for early detection of disease at the convenience of home
  • Rising industrial research programs along with government involvement to develop low cost and single-use devices

Challenges
  • Lacks the regulatory approvals


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are OraSure Technologies (United States), Xiamen Boson Biotech Co. Ltd. (China), Hunan Runmei Gene Technology Co. Ltd. (China), Diagnostics Automation/Cortex Diagnostics Inc. (United States) and Guangzhou Decheng Biotechnology Co. Ltd. (China). Considering Market by Indication, the sub-segment i.e. Malaria will boost the At-home Saliva Testing Kit market. Considering Market by Distribution Channel, the sub-segment i.e. Drugstores will boost the At-home Saliva Testing Kit market.

On May 8, 2020, Rutgers’ RUCDR Infinite Biologics received an amended emergency use authorization from the FDA late Thursday for the first SARS-CoV-2 coronavirus test that will allow people to collect their own saliva at home and send it to a lab for results.

What Can be Explored with the At-home Saliva Testing Kit Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global At-home Saliva Testing Kit Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in At-home Saliva Testing Kit
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global At-home Saliva Testing Kit market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in At-home Saliva Testing Kit market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, At-home Saliva Testing Kit Provider, Government Regulatory and Research Organizations, End-Use Industries and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Test Strip
  • Cassette
By Indication
  • Malaria
  • Ovulation
  • HIV
  • COVID
  • Others

By Distribution Channel
  • Drugstores
  • Retail Pharmacies
  • Hospital Chain Pharmacies
  • Online Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising adoption of self-help and do-it-yourself (DIY) test kits due to convenience and rapid results
      • 3.2.2. Increasing incidence of diseases such as HIV
    • 3.3. Market Challenges
      • 3.3.1. Lacks the regulatory approvals
    • 3.4. Market Trends
      • 3.4.1. Growing research and development activities to develop more specific saliva-based test kits
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global At-home Saliva Testing Kit, by Type, Indication, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global At-home Saliva Testing Kit (Value)
      • 5.2.1. Global At-home Saliva Testing Kit by: Type (Value)
        • 5.2.1.1. Test Strip
        • 5.2.1.2. Cassette
      • 5.2.2. Global At-home Saliva Testing Kit by: Indication (Value)
        • 5.2.2.1. Malaria
        • 5.2.2.2. Ovulation
        • 5.2.2.3. HIV
        • 5.2.2.4. COVID
        • 5.2.2.5. Others
      • 5.2.3. Global At-home Saliva Testing Kit by: Distribution Channel (Value)
        • 5.2.3.1. Drugstores
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Hospital Chain Pharmacies
        • 5.2.3.4. Online Pharmacies
      • 5.2.4. Global At-home Saliva Testing Kit Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. At-home Saliva Testing Kit: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. OraSure Technologies (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Xiamen Boson Biotech Co. Ltd. (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hunan Runmei Gene Technology Co. Ltd. (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Diagnostics Automation/Cortex Diagnostics Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Guangzhou Decheng Biotechnology Co. Ltd. (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global At-home Saliva Testing Kit Sale, by Type, Indication, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global At-home Saliva Testing Kit (Value)
      • 7.2.1. Global At-home Saliva Testing Kit by: Type (Value)
        • 7.2.1.1. Test Strip
        • 7.2.1.2. Cassette
      • 7.2.2. Global At-home Saliva Testing Kit by: Indication (Value)
        • 7.2.2.1. Malaria
        • 7.2.2.2. Ovulation
        • 7.2.2.3. HIV
        • 7.2.2.4. COVID
        • 7.2.2.5. Others
      • 7.2.3. Global At-home Saliva Testing Kit by: Distribution Channel (Value)
        • 7.2.3.1. Drugstores
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Hospital Chain Pharmacies
        • 7.2.3.4. Online Pharmacies
      • 7.2.4. Global At-home Saliva Testing Kit Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. At-home Saliva Testing Kit: by Type(USD Million)
  • Table 2. At-home Saliva Testing Kit Test Strip , by Region USD Million (2015-2020)
  • Table 3. At-home Saliva Testing Kit Cassette , by Region USD Million (2015-2020)
  • Table 4. At-home Saliva Testing Kit: by Indication(USD Million)
  • Table 5. At-home Saliva Testing Kit Malaria , by Region USD Million (2015-2020)
  • Table 6. At-home Saliva Testing Kit Ovulation , by Region USD Million (2015-2020)
  • Table 7. At-home Saliva Testing Kit HIV , by Region USD Million (2015-2020)
  • Table 8. At-home Saliva Testing Kit COVID , by Region USD Million (2015-2020)
  • Table 9. At-home Saliva Testing Kit Others , by Region USD Million (2015-2020)
  • Table 10. At-home Saliva Testing Kit: by Distribution Channel(USD Million)
  • Table 11. At-home Saliva Testing Kit Drugstores , by Region USD Million (2015-2020)
  • Table 12. At-home Saliva Testing Kit Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 13. At-home Saliva Testing Kit Hospital Chain Pharmacies , by Region USD Million (2015-2020)
  • Table 14. At-home Saliva Testing Kit Online Pharmacies , by Region USD Million (2015-2020)
  • Table 15. South America At-home Saliva Testing Kit, by Country USD Million (2015-2020)
  • Table 16. South America At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 17. South America At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 18. South America At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 19. Brazil At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 20. Brazil At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 21. Brazil At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 22. Argentina At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 23. Argentina At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 24. Argentina At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 25. Rest of South America At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 26. Rest of South America At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 27. Rest of South America At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 28. Asia Pacific At-home Saliva Testing Kit, by Country USD Million (2015-2020)
  • Table 29. Asia Pacific At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 30. Asia Pacific At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 31. Asia Pacific At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 32. China At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 33. China At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 34. China At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 35. Japan At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 36. Japan At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 37. Japan At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 38. India At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 39. India At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 40. India At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 41. South Korea At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 42. South Korea At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 43. South Korea At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 44. Taiwan At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 45. Taiwan At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 46. Taiwan At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 47. Australia At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 48. Australia At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 49. Australia At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 53. Europe At-home Saliva Testing Kit, by Country USD Million (2015-2020)
  • Table 54. Europe At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 55. Europe At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 56. Europe At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 57. Germany At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 58. Germany At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 59. Germany At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 60. France At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 61. France At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 62. France At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 63. Italy At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 64. Italy At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 65. Italy At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 66. United Kingdom At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 67. United Kingdom At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 68. United Kingdom At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 69. Netherlands At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 70. Netherlands At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 71. Netherlands At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 72. Rest of Europe At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 73. Rest of Europe At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 74. Rest of Europe At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 75. MEA At-home Saliva Testing Kit, by Country USD Million (2015-2020)
  • Table 76. MEA At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 77. MEA At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 78. MEA At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 79. Middle East At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 80. Middle East At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 81. Middle East At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 82. Africa At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 83. Africa At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 84. Africa At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 85. North America At-home Saliva Testing Kit, by Country USD Million (2015-2020)
  • Table 86. North America At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 87. North America At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 88. North America At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 89. United States At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 90. United States At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 91. United States At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 92. Canada At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 93. Canada At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 94. Canada At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 95. Mexico At-home Saliva Testing Kit, by Type USD Million (2015-2020)
  • Table 96. Mexico At-home Saliva Testing Kit, by Indication USD Million (2015-2020)
  • Table 97. Mexico At-home Saliva Testing Kit, by Distribution Channel USD Million (2015-2020)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. At-home Saliva Testing Kit: by Type(USD Million)
  • Table 104. At-home Saliva Testing Kit Test Strip , by Region USD Million (2021-2026)
  • Table 105. At-home Saliva Testing Kit Cassette , by Region USD Million (2021-2026)
  • Table 106. At-home Saliva Testing Kit: by Indication(USD Million)
  • Table 107. At-home Saliva Testing Kit Malaria , by Region USD Million (2021-2026)
  • Table 108. At-home Saliva Testing Kit Ovulation , by Region USD Million (2021-2026)
  • Table 109. At-home Saliva Testing Kit HIV , by Region USD Million (2021-2026)
  • Table 110. At-home Saliva Testing Kit COVID , by Region USD Million (2021-2026)
  • Table 111. At-home Saliva Testing Kit Others , by Region USD Million (2021-2026)
  • Table 112. At-home Saliva Testing Kit: by Distribution Channel(USD Million)
  • Table 113. At-home Saliva Testing Kit Drugstores , by Region USD Million (2021-2026)
  • Table 114. At-home Saliva Testing Kit Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 115. At-home Saliva Testing Kit Hospital Chain Pharmacies , by Region USD Million (2021-2026)
  • Table 116. At-home Saliva Testing Kit Online Pharmacies , by Region USD Million (2021-2026)
  • Table 117. South America At-home Saliva Testing Kit, by Country USD Million (2021-2026)
  • Table 118. South America At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 119. South America At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 120. South America At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 121. Brazil At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 122. Brazil At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 123. Brazil At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 124. Argentina At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 125. Argentina At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 126. Argentina At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 127. Rest of South America At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 128. Rest of South America At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 129. Rest of South America At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 130. Asia Pacific At-home Saliva Testing Kit, by Country USD Million (2021-2026)
  • Table 131. Asia Pacific At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 132. Asia Pacific At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 133. Asia Pacific At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 134. China At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 135. China At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 136. China At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 137. Japan At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 138. Japan At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 139. Japan At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 140. India At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 141. India At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 142. India At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 143. South Korea At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 144. South Korea At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 145. South Korea At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 146. Taiwan At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 147. Taiwan At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 148. Taiwan At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 149. Australia At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 150. Australia At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 151. Australia At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 154. Rest of Asia-Pacific At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 155. Europe At-home Saliva Testing Kit, by Country USD Million (2021-2026)
  • Table 156. Europe At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 157. Europe At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 158. Europe At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 159. Germany At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 160. Germany At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 161. Germany At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 162. France At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 163. France At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 164. France At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 165. Italy At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 166. Italy At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 167. Italy At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 168. United Kingdom At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 169. United Kingdom At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 170. United Kingdom At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 171. Netherlands At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 172. Netherlands At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 173. Netherlands At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 174. Rest of Europe At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 175. Rest of Europe At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 176. Rest of Europe At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 177. MEA At-home Saliva Testing Kit, by Country USD Million (2021-2026)
  • Table 178. MEA At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 179. MEA At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 180. MEA At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 181. Middle East At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 182. Middle East At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 183. Middle East At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 184. Africa At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 185. Africa At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 186. Africa At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 187. North America At-home Saliva Testing Kit, by Country USD Million (2021-2026)
  • Table 188. North America At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 189. North America At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 190. North America At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 191. United States At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 192. United States At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 193. United States At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 194. Canada At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 195. Canada At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 196. Canada At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 197. Mexico At-home Saliva Testing Kit, by Type USD Million (2021-2026)
  • Table 198. Mexico At-home Saliva Testing Kit, by Indication USD Million (2021-2026)
  • Table 199. Mexico At-home Saliva Testing Kit, by Distribution Channel USD Million (2021-2026)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global At-home Saliva Testing Kit: by Type USD Million (2015-2020)
  • Figure 5. Global At-home Saliva Testing Kit: by Indication USD Million (2015-2020)
  • Figure 6. Global At-home Saliva Testing Kit: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America At-home Saliva Testing Kit Share (%), by Country
  • Figure 8. Asia Pacific At-home Saliva Testing Kit Share (%), by Country
  • Figure 9. Europe At-home Saliva Testing Kit Share (%), by Country
  • Figure 10. MEA At-home Saliva Testing Kit Share (%), by Country
  • Figure 11. North America At-home Saliva Testing Kit Share (%), by Country
  • Figure 12. Global At-home Saliva Testing Kit share by Players 2020 (%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. OraSure Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 15. OraSure Technologies (United States) Revenue: by Geography 2020
  • Figure 16. Xiamen Boson Biotech Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 17. Xiamen Boson Biotech Co. Ltd. (China) Revenue: by Geography 2020
  • Figure 18. Hunan Runmei Gene Technology Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 19. Hunan Runmei Gene Technology Co. Ltd. (China) Revenue: by Geography 2020
  • Figure 20. Diagnostics Automation/Cortex Diagnostics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Diagnostics Automation/Cortex Diagnostics Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Guangzhou Decheng Biotechnology Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 23. Guangzhou Decheng Biotechnology Co. Ltd. (China) Revenue: by Geography 2020
  • Figure 24. Global At-home Saliva Testing Kit: by Type USD Million (2021-2026)
  • Figure 25. Global At-home Saliva Testing Kit: by Indication USD Million (2021-2026)
  • Figure 26. Global At-home Saliva Testing Kit: by Distribution Channel USD Million (2021-2026)
  • Figure 27. South America At-home Saliva Testing Kit Share (%), by Country
  • Figure 28. Asia Pacific At-home Saliva Testing Kit Share (%), by Country
  • Figure 29. Europe At-home Saliva Testing Kit Share (%), by Country
  • Figure 30. MEA At-home Saliva Testing Kit Share (%), by Country
  • Figure 31. North America At-home Saliva Testing Kit Share (%), by Country
List of companies from research coverage that are profiled in the study
  • OraSure Technologies (United States)
  • Xiamen Boson Biotech Co. Ltd. (China)
  • Hunan Runmei Gene Technology Co. Ltd. (China)
  • Diagnostics Automation/Cortex Diagnostics Inc. (United States)
  • Guangzhou Decheng Biotechnology Co. Ltd. (China)
Select User Access Type

Key Highlights of Report


Nov 2021 229 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global At-home Saliva Testing Kit Market Quantitative research analysis
Global At-home Saliva Testing Kit Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The At-home Saliva Testing Kit market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global At-home Saliva Testing Kit market are OraSure Technologies (United States), Xiamen Boson Biotech Co. Ltd. (China), Hunan Runmei Gene Technology Co. Ltd. (China), Diagnostics Automation/Cortex Diagnostics Inc. (United States) and Guangzhou Decheng Biotechnology Co. Ltd. (China), to name a few.
"Growing research and development activities to develop more specific saliva-based test kits" is seen as one of major influencing trends for At-home Saliva Testing Kit Market during projected period 2020-2026.

Know More About Global At-home Saliva Testing Kit Market Report?

Have a Query? Click Here

Other Related Reports

Viral Transport Kit Comprehensive Study by Type (Tissue Culture Medium, Glycerol Transport Medium), Application (Herpes Simplex Type I, Herpes Simplex Type II, Cytomegalovirus (CMV), Influenza A, Inf...
$ 3800
Human Rabies Treatment - Comprehensive Study by Type (Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Others), Application (Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis), Dist...
$ 3450
Fibrate Drugs Comprehensive Study by Type (Gemfibrozil, Lofibrate, Fenofibric Acids, Fenofibrates), End users (Hospitals, Homecare, Specialty clinics, Others), Distribution Channel (Hospital pharmacy...
$ 3350
Portal Hypertension Drugs Comprehensive Study by Type (Prehepatic, Intrahepatic, Posthepatic), Treatment (Endoscopic Therapy, Surgery, Radiology, Others), Drug Class (Vasoconstrictors, Vasodilators, ...
$ 3450
Vaginitis Drug Comprehensive Study by Drugs (Nitro Imidazole Compounds, Lincosamide Antibiotics, Triazoles, Imidazoles), Schedule of Drug (Rx, OTC), Route of Adminstration (Oral, Cutaneous, Vaginal),...
$ 3650
Penicillin Drugs Comprehensive Study by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other), Bacteria (Streptococcus pneumonia, Listeria, Neisseria gonorrhoea, Clo...
$ 3750